Issue 1/2016
Content (8 Articles)
Prescribing Ceftolozane/Tazobactam for Pediatric Patients: Current Status and Future Implications
Seetha M. Tamma, Alice J. Hsu, Pranita D. Tamma
Recommendations Concerning the First-Line Treatment of Children with Tuberculosis
Nicola Principi, Luisa Galli, Laura Lancella, Marina Tadolini, Giovanni Battista Migliori, Alberto Villani, Susanna Esposito
Emerging Agents for the Management of Nephrotic Syndrome: Progress to Date
Keisha L. Gibson, Panupong Hansrivijit, Maria E. Ferris
Pharmacologic Management of Pediatric Hypertension
Jason Misurac, Kristen R. Nichols, Amy C. Wilson
Pharmacotherapy for Pediatric Generalized Anxiety Disorder: A Systematic Evaluation of Efficacy, Safety and Tolerability
Eric T. Dobson, Jeffrey R. Strawn
Enhanced Paediatric Pharmacovigilance at the European Medicines Agency: A Novel Query Applied to Adverse Drug Reaction Reports
Kevin V. Blake, Agnes Saint-Raymond, Cosimo Zaccaria, Francois Domergue, Benjamin Pelle, Jim Slattery
Tablet/Capsule Size Variation Among the Most Commonly Prescribed Medications for Children in the USA: Retrospective Review and Firsthand Pharmacy Audit
Laura Jacobsen, Kathy Riley, Brian Lee, Kathleen Bradford, Ravi Jhaveri
Zolmitriptan Nasal Spray: A Review in Acute Migraine in Pediatric Patients 12 Years of Age or Older
Kate McKeage